<DOC>
	<DOCNO>NCT00625521</DOCNO>
	<brief_summary>Lupus Erythematosus ( LE ) autoimmune disorder include broad spectrum clinical form . One form , Discoid Lupus Erythematosus ( DLE ) chronic disfigure disease confine skin . The aim pivotal trial investigate efficacy safety ASF-1096 cream 0.5 % treatment patient DLE SLE present newly develop discoid lesion .</brief_summary>
	<brief_title>Efficacy Safety ASF-1096 Cream 0.5 % Treatment Discoid Lupus Erythematosus ( DLE ) Lesions</brief_title>
	<detailed_description />
	<mesh_term>Lupus Erythematosus , Systemic</mesh_term>
	<mesh_term>Lupus Erythematosus , Discoid</mesh_term>
	<criteria>A clinical diagnosis either DLE SLE Histological result biopsy confirm diagnosis ( biopsy take screening ) Is prepared grant authorise person access medical record Has sign inform consent Has active skin disease DLE another progressive serious disease interferes study outcome Has scarring target lesion Systemic treatment SLE</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2008</verification_date>
	<keyword>Discoid lupus erythematosus</keyword>
</DOC>